Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OTC Homeopathic Labels Must Include Scientific Disclaimers – FTC

Executive Summary

US trade regulator will require an "inherent contradiction" for homeopathic OTC labels: disclaimers to FDA-compliant label indications indicating a lack of scientific evidence that the product works.


Related Content

Crack-Down On Homeopathic Products Pushed By EU Science Advisory Council
Congress Recommends Public Rulemaking In Puerto Rico: Health & Wellness Industry News Roundup
FTC Homeopathic Disclaimer Policy Should Prompt FDA Changes – Advocacy Group
FTC Homeopathic Advertising Review Spurs Broader Disclaimer Suggestion, Opens New Stage For RCT Debate
Naloxone Switch: Door Opener For Other NDAs That Swing On Consumer Education
Homeopathic Divide: FDA Talks Pre-Market Approval As Industry Floats Label Changes
Homeopathic Claims Have FTC Searching For Remedy To Regulatory Conflict With FDA





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts